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injury has been shown to adversely aﬀect nerve regenera-
tion and evidence suggests that mannose-6-phosphate
(M6P), a potential scar reducing agent that aﬀects trans-
forming growth factor (TGF)-b activation, may enhance
nerve regeneration. In this study we utilized thy-1-YFP-H
mice – a transgenic strain expressing yellow ﬂuorescent
protein (YFP) within a subset of axons – to enable visual
analysis of axons regenerating through a nerve graft. Using
this strain of mouse we have developed analysis techniques
to visualize and quantify regeneration of individual axons
across the injury site following the application of either
M6P or vehicle to the site of nerve injury. No signiﬁcant dif-
ferences were found in the proportion of axons regenerating
through the graft between M6P- and vehicle-treated grafts at
any point along the graft length. Maximal sprouting
occurred at 1.0 mm from the proximal graft ending in both
groups. The maximum change in sprouting levels for both
treatment groups occurred between the graft start and 0.5-
mm interval for both treatment groups. The diﬀerence
between repair groups was signiﬁcant at this point with a
greater increase seen in the vehicle group than the M6P
group. The average length of axons regenerating across
the initial graft entry was signiﬁcantly shorter in M6P- than
in vehicle-treated grafts, indicating that they encountered
less impedance. Application of M6P appears to reduce
the disruption of regenerating axons and may therefore
facilitate quicker recovery; this is likely to result from altered
scar tissue formation in M6P grafts in the early stages of
recovery. This study also establishes the usefulness ofhttp://dx.doi.org/10.1016/j.neuroscience.2014.08.034
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INTRODUCTION
Peripheral nerve injuries are a common occurrence
worldwide with over 300,000 cases annually in Europe
alone (Ciardelli and Chiono, 2006). Most occur through
domestic, workplace and traﬃc accidents but a signiﬁcant
number are caused by surgical procedures (Ciaramitaro
et al., 2010). In one study Kretschmer et al. (2001)
reported that 17.4% of traumatic nerve lesions treated
over a 9-year period at one nerve-injury centre were iatro-
genic in origin.
It has been well documented that peripheral nerves
are able to undergo regeneration following injury;
however functional recovery following surgery is
unpredictable and is rarely complete (Robinson et al.,
2000). The formation of intra-neural scarring following
peripheral nerve injury has long been considered to
adversely aﬀect functional recovery in peripheral nerves,
with Bora (1967) noting a negative correlation between
the quantity of ﬁbrous tissue at a nerve repair site and
the overall level of functional recovery. More recently
Atkins et al. (2006b) provided ‘proof of concept’ in a study
that demonstrated that reducing intra-neural scarring
improved nerve regeneration. In Atkins’ study, regenera-
tion of the sciatic nerve in wild-type (WT) mice was com-
pared with that in two transgenic strains – one with an
increased propensity for scarring (interleukin (IL)-4/IL-10
null mice) and the other with a decreased propensity for
scarring (M6PR/IGF2 null mice) – with the results demon-
strating that reducing the level of scarring at the injury site
could improve nerve regeneration.
Alteration of the ratios of transforming growth factor
(TGF)-b1, -b2 and -b3 at the site of injury has been
shown to aﬀect the level of scar formation in dermal
wounds (Shah et al., 1994, 1995), with neutralisation of
TGF-b1 and -b2 using antibodies, and exogenous addi-
tion of TGF-b3 reducing scarring in rat models. Neutrali-
sation of TGF-b1 and -b2 at the site of a nerve injury
has also been shown to signiﬁcantly reduce the level of
scarring (Atkins et al., 2006a). However the eﬀect upon/licenses/by/3.0/).
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reporting no improvement in regeneration and Davison
et al. (1999), who neutralised only TGF-b1, reporting a
signiﬁcant improvement.
As TGF-b1 is linked to promoting the transition of
Schwann cells into their more active, proliferating, non-
myelinating phenotype following nerve injury (Einheber
et al., 1995), the complete removal of TGF-b1 from the injury
sitemay negatively aﬀect some aspects of regeneration. An
alternative approach to using TGF-b antibodies to reduce
intra-neural scarring is the use of mannose-6-phosphate
(M6P); which has been shown to reduce scarring in dermal
wounds (McCallion and Ferguson, 1996). TGF-b is
secreted from cells in a latent form bound to a latency-
associated peptide (LAP) and latent TGF-b-binding protein
(LTBP), and only becomes active once LAP and LTBP are
removed; M6P occupies receptors used to trigger the
removal of LAP and LTBP and as such reduces local
TGF-b activation (McCallion and Ferguson, 1996).
A previous study carried out in our laboratory, looking at
the eﬀects of M6P on nerve regeneration, found that the
application of M6P to a nerve repair did produce a
signiﬁcant improvement in nerve regeneration compared
to controls at 6 weeks post repair (Ngeow et al., 2011b).
However, this was not accompanied by a reduction in scar-
ring, and at 12 weeks post repair there was no signiﬁcant
diﬀerence between M6P-treated and control repairs. The
analytical methods used by the authors to assess nerve
regeneration (walking gait analysis and electrophysiology)
are well-established methods; however, they do have
limitations in that they only indicate whether a particular
treatment has improved regeneration and give no indica-
tion of why some axons fail to cross the repair site.
In this study we utilized thy-1-YFP-H mice – a
transgenic strain expressing yellow ﬂuorescent protein
(YFP) within a subset of axons (Feng et al., 2000) – to
enable visual analysis of axons regenerating through a
nerve graft. This strain of mouse has been used in previ-
ous studies of peripheral nerve regeneration (English
et al., 2005, 2007; Groves et al., 2005) as it allows the
path of individual axons to be traced across the injury site.
Using this strain of mouse we have developed new meth-
ods of analysis to visualize and quantify regeneration of
individual axons following the application of either M6P
or vehicle to the site of nerve injury.EXPERIMENTAL PROCEDURES
Surgical procedure
Fifty-three mice aged between 9 and 12 weeks (at the
time of the initial surgery) were used in this study: 33
thy-1-YFP-H (YFP+) mice and 20 C57B/6J (WT) mice.
The WT mice used were littermates of the YFP+ mice.
The experiments were carried out under appropriate UK
Home Oﬃce approval, in accordance with the Animals
(Scientiﬁc Procedures) Act 1986. The experimental
model involved unilateral repair of the common ﬁbular
nerve with a nerve graft treated with either M6P
(600 mM) or vehicle (phosphate-buﬀered saline). The
experimental groups were: M6P-treated grafts (n= 10
YFP+ mice and n= 10 WT mice), vehicle-treatedgrafts (n= 10 YFP+ mice and 10 WT mice), and
uninjured controls (n= 10 YFP+ mice). A further group
(n= 3 YFP+ mice) was used to assess the level of
residual ﬂuorescence in the nerve distal to the injury site
when graft repair was not carried out.
Under general anesthesia (2–3% isoﬂurane; Abbott
Laboratories, Maidenhead, UK), the common ﬁbular
nerve of a WT mouse was exposed and freed from the
surrounding tissue. A section of nerve (5 mm minimum
length) was then removed and placed in a numbered
vial containing either M6P or vehicle (randomized with
the investigator blind to the contents). The nerve tissue
remained immersed in the solution for 30 min. Following
the removal of the nerve, WT animals were euthanized
by cervical dislocation while under deep anesthesia.
During the period of immersion a YFP+ littermate was
prepared to receive the graft. Under anesthesia (2–3%
isoﬂurane), the right common ﬁbular nerve was exposed
and carefully freed from the surrounding tissue. A 5-mm
silicone trough was then inserted beneath the nerve, and
the nerve was sectioned. A gap of 2.5–3 mm was created
between the proximal and distal ends by careful trimming
and the treated WT graft (as described above) was
trimmed to ﬁt the gap. The graft and nerve ends were
then aligned and the graft was secured in place with ﬁbrin
glue, consisting of ﬁbrinogen (10 mg/ml; Sigma–Aldrich,
Gillingham, Dorset, UK) and thrombin (40 units/ml;
Sigma–Aldrich, UK) in a 1:1 ratio, and allowed to set for
5 min. Once the repair was secure the silicone trough
was carefully removed and the wound closed. A single
dose of analgesic was administered subcutaneously
(0.01 ml buprenorphine hydrochloride 0.3 mg/ml;
Vetergesic, Alstoe Animal Health, Sheriﬀ Hutton, UK)
and the mice were then allowed to recover for 2 weeks.
Following the recovery period, mice were re-
anaesthetized (fentanyl/ﬂuanisone, 0.8 ml/kg [Hypnorm,
Janssen Animal Health, High Wycombe, UK] and
midazolam, 4 mg/kg [Hypnovel, Roche Products Ltd,
Welwyn Garden City, UK]; ip) and the common ﬁbular
nerve exposed and freed from surrounding tissue. The
skin was sutured to a brass ring to form a pool, which
was ﬁlled with 4% paraformaldehyde for 30 min to ﬁx
the nerve. Following ﬁxation the nerve was excised and
mounted on a microscope slide using Vectashield, and
the mouse culled under deep anesthesia by cervical
dislocation. The uninjured control nerves were also
obtained using this procedure.
To assess residual ﬂuorescence in the portion of the
nerve distal to the injury, the common ﬁbular nerve in
three YFP+ mice was exposed and sectioned as
described above. Following sectioning the proximal end
was tied oﬀ with a silk suture to prevent regeneration of
axons. Following a 2-week recovery period the proximal
and distal portions of the injured nerves were ﬁxed and
excised as described above.
Image acquisition and processing
Images of nerves were acquired with ﬂuorescent
microscopy (Zeiss Axioplan 2 imaging microscope with
QImaging Retiga 1300R camera) using the Optigrid
Structured Illumination system and Image Pro-Plus
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USA). Images were acquired with a 10 objective in
sequential steps in the z-axis. The composite images
shown in the ﬁgures were created from stacks of thirty
10-lm-thick sections throughout the entire thickness of
the nerve. To obtain images of the full length of the
nerve, stacks were acquired from multiple adjoining
microscope ﬁelds and the composite images were
joined using Adobe Photoshop (Fig. 1).
Minimal image processing with Adobe Photoshop was
applied to the joined images used for analysis; this
consisted of adjusting brightness/contrast and image
exposure in order to improve axon clarity.Image analysis
All analysis was carried out with the assessor blind to the
treatment received by each nerve graft.
The ﬁrst point at which abnormal morphology could be
determined by observation was marked by a
perpendicular line. Using this line as a reference, further
lines were drawn at 0.5-mm intervals (Fig. 1); one
0.5 mm proximal to the reference line and the remainder
up to 3.5 mm distal to the reference line. The analysisFig. 1. Reconstructed nerve image. A typical reconstructed nerve image (top)
traced from the 3.5-mm interval to the graft start (green lines indicating duplsite proximal to the reference line was referred to as the
pre-graft interval with the other sites referred to as their
distance in mm from the reference line (0.5 mm,
1.0 mm, etc.). For uninjured controls a perpendicular
line was marked 0.5 mm from the proximal end of the
nerve section and further lines were marked at 0.5-mm
intervals distal to the ﬁrst.
A sprouting index was calculated for each interval by
counting the number of axons at the selected interval
and dividing by the number of axons at the pre-graft
interval. This gives an indication of whether the number
of axons at a speciﬁc point has increased or decreased.
Additionally, at each interval the change in sprouting
index compared to the previous interval was calculated.
In order to calculate the number of individual axons
from the graft start that successfully regenerated
through the length of the graft, axons at the 3.5-mm
interval were traced back along their length to the graft
start (Fig. 1). A total of 75% of the axons present at the
3.5-mm interval were traced. This was considered to be
the largest percentage of axons that could be accurately
traced. The trace ﬁnished either when the axon reached
the graft start point or joined up with a branch point of a
previously traced axon. It was decided to trace axons inand the same image with 0.5-mm intervals marked and sample axons
icate branches of the axons traced in red).
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the 3.5-mm interval would involve frequent subjective
decisions to be made with regard to which axon branch
to follow and would aﬀect repeatability.
Finally, the shortest direct route between the 0.0-mm
and 1.5-mm intervals was measured along with the
length of the traced axons over the same distance
(ImageJ, National Institutes of Health, Bethesda, MD,
USA) (Fig. 2); the 1.5-mm interval was the ﬁrst interval
beyond the graft entry disruption in the majority of
repairs. This was used to calculate the average
percentage of axon length above the minimum possible
per graft to provide an indication of the level of axonal
disruption as they entered the graft. Theoretically, axons
with a fairly clear, unobstructed path to follow would be
shorter than those having to make their way around
obstructions such as scar tissue.Statistical analysis
Statistical comparisons between groups were made using
GraphPad Prism (version 5.00 for Windows; GraphPad
Software, San Diego, CA, USA). For comparison of
sprouting index and axon tracing, a two-way analysis of
variance (ANOVA) (followed by Student’s t-test with
Bonferroni’s correction) was performed to determineFig. 2. Enlarged view of the initial injury site. The length of traced axons
compared to the direct measurement between the two points.diﬀerences between repair types and also repair
position. Comparisons of axon disruption were made
using a one-way ANOVA with Student’s t-test with
Bonferroni’s correction. Diﬀerences were considered
signiﬁcant at p< 0.05.
RESULTS
All animals recovered well from the initial surgery with no
signs of autotomy (self-mutilation of the denervated
region) or infection. In all three animals where no repair
was carried out, residual ﬂuorescence in the distal
portion of the nerve was minimal consisting of only
small ﬂuorescent ﬂecks (Fig. 3B). This conﬁrmed that
any ﬂuorescence in the graft and distal regions of
repaired animals was from regenerating axons.
Axon sprouting
Nerves from normal (uninjured) controls displayed clear
individual nerve axons running in a near parallel course
throughout the portion of nerve examined and no
sprouting was observed (Fig. 3A). Following injury and
repair signiﬁcant sprouting was seen in both M6P- and
vehicle-treated groups (Figs. 1, 2 and 4). Sprouting was
most apparent where the axons entered and exited the
graft (Fig. 4).was measured between the graft start and the 1.5-mm interval and
Fig. 3. Eﬀect of injury on axons distal to injury site. (A) Typical uninjured common ﬁbular nerve section. (B) Transected and unrepaired common
ﬁbular nerve showing proximal and distal portions 2 weeks post injury; only minimal ﬂuorescence is present in the distal portion.
Fig. 4. Images of nerve grafts. Typical vehicle- (top) and M6P-treated (bottom) nerve graft images. No obvious visual diﬀerences were noted
between vehicle- and M6P-treated graft images prior to analysis.
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Fig. 5. Quantiﬁcation of sprouting. (A) Sprouting index values for each 0.5-mm interval. Diﬀerences in sprouting between repair groups were not
signiﬁcant; compared to uninjured controls sprouting in M6P- and vehicle-treated groups was signiﬁcantly increased at the 0.5-mm and 1.0-mm
intervals and in the M6P-treated group was signiﬁcantly decreased at the 3.5-mm interval. Statistical test: two-way ANOVA with Student’s t-test with
Bonferroni’s correction; ⁄p< 0.05 compared to uninjured controls; ⁄⁄⁄p< 0.001 compared to uninjured controls. (B) Changes in sprouting index
levels compared to proximal adjacent site. Statistical test: two-way ANOVA with Student’s t-test with Bonferroni’s correction; ⁄⁄p< 0.01 compared
to vehicle group; p< 0.01 compared to uninjured controls; p< 0.001 compared to uninjured controls.
28 A. J. Harding et al. / Neuroscience 279 (2014) 23–32
Fig. 6. Proportion of axons from the start point represented at each subsequent site. No signiﬁcant diﬀerences were observed between repair
groups in the proportion of axons from the 0.0-mm site represented at each subsequent site. However, both repair groups had a signiﬁcantly lower
proportion of axons from the 0.0-mm interval compared to the uninjured group from the 1.0-mm interval to the 3.5-mm interval. Statistical test: two-
way ANOVA with Student’s t-test with Bonferroni’s correction; ⁄⁄⁄p< 0.001 compared to uninjured controls.
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grafts had a slightly lower sprouting index than the
vehicle-treated group at the 0.5-mm and 1.0-mm
intervals; this diﬀerence between treatment groups was
maintained for the remaining intervals (Fig. 5A).
However, these diﬀerences were not statistically
signiﬁcant (p> 0.05; two-way ANOVA with Student’s t-
test with Bonferroni’s correction).
For both M6P- and vehicle-treated groups the
maximum sprouting index values were observed at the
0.5-mm (160.2% [SEM= 16.3] for M6P and 178.1
[12.8] for vehicle) and 1.0-mm (169.4 [19.8] for M6P
and 176.8 [26.6] for vehicle) intervals with values in both
groups signiﬁcantly higher (p< 0.001) than those of the
uninjured group (99.1% [1.4] at 0.5 mm and 96.2 [1.1] at
1.0 mm). The lowest sprouting index for both repair
groups was observed at the 3.5-mm (distal nerve
stump) interval (52.5% [8.7] for M6P and 77.6% [14.4]
for vehicle) with the sprouting index in the M6P-treated
group being signiﬁcantly lower (p< 0.05) than that for
the uninjured group (98.5% [1.3]).
The maximum change in sprouting index compared to
the previous level for both treatment groups occurred
between the graft start and the 0.5-mm interval
(Fig. 5B). The diﬀerence between repair groups was
signiﬁcant at this point (p< 0.01) with a greater
increase seen in the vehicle-treated group (75.2%
[SEM= 13.9] than the M6P-treated group (38.1%
[11.3]). At this point the increase in sprouting index in
both repair groups was signiﬁcantly greater (p< 0.01
for M6P and p< 0.001 for vehicle) than that seen inuninjured controls (2.8% [1.5]). The sprouting index
values in both repair groups remained stable between
the 0.5-mm and 1.0-mm intervals and then fell in both
treatment groups between the 1.0-mm and 1.5-mm
intervals. The sprouting index then continued to fall at a
similar rate in both treatment groups between the
remaining intervals (Fig. 5B).
Axon tracing
The proportion of individual axons from the start point
(0.0 mm) represented at each interval along the graft
declined at a similar rate in both M6P- and vehicle-
treated grafts. No diﬀerences were noted between
groups at each individual interval. In both groups
approximately half of the axons at the start point failed
to reach the 1.5-mm interval and three-quarters failed to
reach the end of the graft (3.5-mm interval) (Fig. 6).
Axon disruption
When crossing the proximal repair site the average
increase in axon length between the graft start and the
1.5-mm interval was signiﬁcantly lower (p < 0.001) in
the M6P-treated group (13.6% [SEM= 1.2]) than in the
vehicle-treated group (20.5% [7.5]) (Fig. 7).
DISCUSSION
This study has allowed clear visualization of axon
disruption following graft repair. It was clear following
nerve imaging alone (Fig. 4) that a large amount of
Fig. 7. Comparison of axonal disruption. (A) Comparison of axon disruption in M6P- (left) and vehicle-treated repairs (right) across the initial 1.5 mm
of the repair. An individual traced axon is used to indicate diﬀerences in axon length/disruption. (B) Average increase in axon length across the initial
injury site. Axons in the M6P group were on average 13.55% (SEM= 1.17) longer than the distance between the graft start and 1.5-mm interval;
axons in the vehicle group were 20.51% (2.36) longer. Statistical test: one-way ANOVA with Student’s t-test with Bonferroni’s correction; ⁄p< 0.05
compared to vehicle group; p< 0.001 compared to uninjured controls.
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junction between the proximal and distal nerve endings
and the graft. This was conﬁrmed after analysis by thesigniﬁcant increase in sprouting index in both repair
groups compared with the baseline for uninjured nerves
at the 0.5-mm and 1.0-mm intervals (Fig. 5A). The
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is known to be detrimental to nerve regeneration, with
previous studies showing direct suturing under mild
tension to be preferable to grafts – this despite the
adverse eﬀects on regeneration of tension at the repair
site (Rodkey et al., 1980; Wong and Scott, 1991).
Regenerating axons will often branch into two or more
sprouts following injury, with surplus axon branches
degenerating with time (Bray and Aguayo, 1974; Toft
et al., 1988). This branching increases the probability of
an axon being able to navigate through to the distal nerve
stump. Xu et al. (2008) found that axonal sprouting was
signiﬁcantly increased in a 20-mm-long nerve crush injury
compared to a 2-mm-long nerve crush injury; this
suggests that increased disruption within the nerve micro-
environment, including that related to the development of
intraneural scarring, can lead to increased axonal sprout-
ing among the regenerating axons. Atkins et al. (2007)
reported that a low dose of the anti-inﬂammatory cytokine
IL-10 signiﬁcantly reduced intra-neural scarring, and
electrophysiological results indicated increased axon
regeneration across the repair site. The axon counts distal
to the repair for IL-10-treated nerves and saline-treated
controls were, however, found to be similar; the reason
for the similarity in axon numbers was thought to be related
to additional sprouting in the saline-treated controls due to
increased intraneural scarring (Atkins et al., 2007).
The application of M6P appears to have a signiﬁcant
impact on the amount of disruption that axons suﬀer at
the early stage of regeneration into the graft. This is
indicated by the signiﬁcantly smaller increase in
sprouting index between the graft start and the 0.5-mm
interval (Fig. 5B) combined with signiﬁcantly shorter
average axon lengths over the initial 1.5-mm portion of
the graft (Fig. 7). A previous study by Ngeow et al.
(2011b) used measurements of compound action poten-
tials to assess nerve regeneration and demonstrated that
the application of M6P signiﬁcantly improves nerve regen-
eration in the early stages of recovery, but that the
improvement is not maintained later in the recovery pro-
cess. The results of our study provide further evidence
that M6P improves nerve regeneration and give an expla-
nation for the ﬁndings of Ngeow et al. (2011a,b). Our data
indicate that the eﬀect of M6P may be due to axons taking
a more direct route across the repair site rather than
regenerating at a faster pace or reducing the time taken
for regeneration to be initiated.
The simplest explanation for the more direct route
taken by axons across the repair site following M6P
treatment is that collagen formation has been reduced
by the inhibition of TGF-b activation. However, the
studies by Ngeow et al. (2011a,b) did not ﬁnd any signif-
icant reduction in collagen following M6P treatment, sug-
gesting that the eﬀects observed here may be due to
diﬀerences in the alignment, density or thickness of the
collagen ﬁbers.
One possibility is that the application of M6P
decreased the production rate of collagen for a short
time following application, resulting in more organized
initial collagen formation. Increased TGF-b1 is known to
reduce the organization of collagen following tissue
injury (Henderson et al., 2012) and increased collagendensity is linked to reduced ﬁbroblast movement through
tissues, which causes decreased alignment of collagen
(Dallon et al., 2001). So a reduction in collagen production
during the early stages of peripheral nerve regeneration
may lead to more preferentially arranged collagen ﬁbers
that help guide regenerating axons rather than obstructing
them. Although previous studies did not ﬁnd a signiﬁcant
reduction in overall collagen levels at 6 weeks post-injury
(Ngeow et al., 2011a,b), it is possible that the collagen
production rate was signiﬁcantly reduced at an earlier
time point, allowing more organized collagen to form
before the eﬀects of M6P are countered and collagen pro-
duction levels return to normal.
The lack of any notable diﬀerence between M6P- and
vehicle-treated groups in terms of the proportion of axons
regenerating from the graft start to the 3.5-mm interval
does not clearly indicate an improvement in functional
recovery. However, the proportion of axons reaching the
distal nerve stump from the graft start is not the only
concern when considering functional recovery. It has
been shown that functional recovery is improved when
axons regenerate faster through a graft (Danielsen
et al., 1994) and that the denervated distal stump
becomes progressively less capable of supporting axon
regeneration over time (Sulaiman and Gordon, 2000). In
addition, prolonged denervation may aﬀect the ability of
muscle ﬁbers to receive regenerating axons (Miyamaru
et al., 2008) and delayed repair has been shown to have
a detrimental eﬀect upon the recovery of muscle mass
and motor function (Kobayashi et al., 1997). With the
application of M6P allowing axons to take a shorter, and
thereby faster, route through the main area of disruption
there is the potential that the axons will reach the distal
stump and their targets more quickly.
Within this study it was not possible to determine
whether axons in M6P-treated grafts had actually
regenerated further during the recovery period
compared to those in vehicle-treated grafts. The reason
for this is that leading axons had already regenerated
past the point where the harvested nerve tissue was
sectioned – just distal to the portion of nerve where the
graft was inserted, the common ﬁbular nerve passes
around the lateral side of the knee joint and is diﬃcult to
access. As ﬂuorescence persists in the distal stump for
between 5 and 10 days (Beirowski et al., 2004) and
regenerating tissues are extremely fragile after 7 days’
recovery (unpublished observations), reliable analysis
after a shorter recovery period would be diﬃcult.CONCLUSION
This study provides further evidence that M6P improves
nerve regeneration in the early stages of nerve repair
and indicates that the improvement is due to axons
crossing the repair site in a quicker, more direct
manner. How M6P eﬀects this improvement is as yet
unclear though it may be as a result of more favourably
arranged collagen ﬁbrils. This study also establishes the
usefulness of our new methods of analysis using the
thy-1-YFP-H mouse strain in tracing the path of axons
32 A. J. Harding et al. / Neuroscience 279 (2014) 23–32across the injury site, and in visualizing and quantifying
regeneration at the level of the individual axon.
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